REFERENCES
- Institute of Medicine. Confronting AIDS: Update 1988. National Academy Press, Washington, D.C. 1988
- Hubbard R. L., Marsden M. E., Cavanaugh E., et al. Role of drug abuse treatment in limiting the spread of AIDS. Rev. Infect. Dis. 1988; 10: 377–384
- Sisk J. E., Hatziandreu E. J., Hughes R. The Effectiveness of Drug Abuse Treatment: Implications for Controlling AIDS/HIV Infection. Background Paper 6, September, 1990. Office of Technology Assessment, Congress of the United States, Washington, D.C., 1990
- Metzger D. S., Navaline H., Woody G. E. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998; 113S1: 97–106
- Hartel D. M., Schoenbaum E. E. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 1998; 113S1: 107–115
- Presidential Commission on the Human Immunodeficiency Virus Epidemic, Report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic, June 24, 1988. U.S. Government Printing Office, Washington, D.C., 1998
- Turner C. F., Miller H. G., Moses L. E. AIDS, Sexual Behavior, and Intravenous Drug Use. National Academy Press, Washington, D.C. 1989
- Rounsaville B., Kleber H. Untreated opiate addicts: how do they differ?. Arch. Gen. Psychiatry 1985; 42: 1072–1077
- Carrol K. M., Rounsaville B. J. Contrast of treatment-seeking and untreated cocaine abusers. Arch. Gen. Psychiatry 1992; 49: 464–471
- Power R., Hartnoll R., Chalmers C. Help-seeking among illicit drug users: differences between a treatment and nontreatment sample. Int. J. Addict. 1992; 27: 887–904
- Watters J. K., Cheng Y. HIV-1 infection and risk among intravenous drug users in San Francisco: preliminary results and implications. Contemp. Drug Probl. 1987; 15: 97–411
- Ross M., Stowe A., Wodak A., et al. A comparison of drug use and HIV infection risk behavior between injecting drug users currently in treatment, previously in treatment, and never in treatment. J. Acquir. Immune Defic. Syndr. 1993; 6: 518–528
- Booth R. E., Crowley T. J., Zhang Y. Substance abuse treatment entry, retention, and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 1996; 42: 11–20
- Darke S., Hall W., Heather N., et al. The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991; 5: 181–185
- Hosmer D. W., Lemeshow S. Applied Logistic Regression. Wiley and Sons, New York 1989
- LaBrie R. A., McAuliffe W. E., Nemeth-Coslett R., et al. The prevalence of HIV infection in a national sample of injection drug users. Handbook on Risk of AIDS: Injection Drug Users and Sexual Partners, B. S. Brown, G. M. Beschner. Greenwood Press, Westport, Connecticut 1993; 16–37
- Zule W. A. Risk and reciprocity: HIV and the injection drug user. J. Psychoactive Drugs 1992; 24: 243–249